PeerView Kidney & Genitourinary Diseases CME/CNE/CPE Video Podcast

PeerView (PVI) is a leading provider of high-quality, innovative continuing education (CME/CE/CPE and MOC) for clinicians and their interprofessional teams. Combining evidence-based medicine and instructional expertise, PeerView activities improve the knowledge, skills, and strategies that support clinical performance and patient outcomes. PeerView makes its educational programming and expert-led presentations and symposia available through its network of popular podcast channels to support specific specialties and conditions. Each episode includes a link to request CME/CE credit for participation. PeerView is solely responsible for the selection of topics, the preparation of editorial content, and the distribution of all materials it publishes.

http://ww2.peerview.com

Eine durchschnittliche Folge dieses Podcasts dauert 1h1m. Bisher sind 151 Folge(n) erschienen. Alle 10 Tage erscheint eine Folge dieses Podcasts.

Gesamtlänge aller Episoden: 6 days 5 hours 24 minutes

subscribe
share






Arjun Balar, MD - Innovative Treatments for Bladder Cancer: Thoughts From the Chair


Go online to PeerView.com/YFM860 to view the activity, download slides and practice aids, and complete the post-test to earn credit.


share








 July 28, 2020  25m
 
 

William K. Oh, MD - Chair’s Take on Innovation in Prostate Cancer: Thoughts on New Evidence


Go online to PeerView.com/UPY860 to view the activity, download slides and practice aids, and complete the post-test to earn credit.


share








 July 18, 2020  36m
 
 

Bradley J. Monk, MD, FACS, FACOG - Chair's Take: Latest and Emerging Evidence of PARP Inhibitors in Ovarian Cancer Management


Go online to PeerView.com/VSY860 to view the activity, download slides and practice aids, and complete the post-test to earn credit.


share








 July 9, 2020  28m
 
 

Finding the Path to Clinically Meaningful Outcomes Among Expanding Treatment Options in Renal Cell Carcinoma


Go online to PeerView.com/KSB860 to view the activity, download slides and practice aids, and complete the post-test to earn credit.


share








 June 25, 2020  1h38m
 
 

Robin Lachmann, MD, PhD / Melissa Wasserstein, MD - Assessing the Potential Role of Emerging Therapies in the Early Diagnosis and Optimal Management of Chronic Visceral Acid Sphingomyelinase Deficiency


Go online to PeerView.com/NPH860 to view the activity, download slides and practice aids, and complete the post-test to earn credit.


share








 June 13, 2020  1h3m
 
 

Bradley J. Monk, MD, FACS, FACOG - Expert Views on the Evolving Role of PARP Inhibitors in the Treatment of Ovarian Cancer


Go online to PeerView.com/BBX860 to view the activity, download slides and practice aids, and complete the post-test to earn credit.


share








 May 16, 2020  34m
 
 

William K. Oh, MD - Mapping the Pathways to Better Patient Outcomes in Prostate Cancer: Personal Insights and Guidance From the Patient CaseBook


Go online to PeerView.com/SEP860 to view the activity, download slides and practice aids, and complete the post-test to earn credit.


share








 May 2, 2020  1h25m
 
 

Arjun Balar, MD - Advancing Bladder Cancer Care With Novel Therapeutics: Where We Are Headed With Immunotherapy, Targeted, and Antibody Options


Go online to PeerView.com/TYB860 to view the activity, download slides and practice aids, and complete the post-test to earn credit.


share








 April 9, 2020  1h14m
 
 

Arjun Balar, MD - Raising the Bar With Innovative Therapy for Bladder Cancer: Insights on Clinical Decision-Making in the New Era of Care


Go online to PeerView.com/MJJ860 to view the activity, download slides and practice aids, and complete the post-test to earn credit.


share








 March 28, 2020  1h16m
 
 

Toni K. Choueiri, MD - How I Think, How I Treat: Understanding and Working With New Immunotherapeutic and Targeted Management Models in Advanced RCC


Go online to PeerView.com/KWJ860 to view the activity, download slides and practice aids, and complete the post-test to earn credit.


share








 February 20, 2020  38m